Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
Newsroom
Recent News
Archives
E-Alerts
Press Kit
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
E-Alerts
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Email:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Archives

Please select a year from the tabs below to begin viewing archived Nutra Pharma press releases.

2011

December 19, 2011
Nutra Pharma Letter to Shareholders
November 30, 2011
Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain
October 28, 2011
Nutra Pharma CEO Interviewed by Wall Street Reporter
October 19, 2011
Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug
October 14, 2011
Nutra Pharma Announces Distributor in Panama for Their Nyloxin Pain Relievers
August 10, 2011
Nutra Pharma Receives Regulatory Approval to Market Nyloxin in India
July 06, 2011
ABC News Online Features Jeff Gottfurcht's Rheumatoid Arthritis Story, Use of Nyloxin and Mount Everest Climb
June 28, 2011
Nutra Pharma Announces Jordan Distributor for Their Nyloxin Pain Relievers
June 03, 2011
Nutra Pharma Announces Exclusive Distributor for Their Nyloxin Pain Relievers in Lebanon
June 01, 2011
World's First Mountain Climber with Rheumatoid Arthritis Successfully Scaled Mount Everest with the Pain Relief Help of Nyloxin™, a Drug from Nutra Pharma Corporation
April 27, 2011
Nutra Pharma Announces Exclusive Distributor for Their Nyloxin Pain Relievers in Venezuela
April 12, 2011
Nutra Pharma Announces Nyloxin™ Distribution Through Innovatix
March 14, 2011
Nutra Pharma Receives Patent for the Use of Cobratoxin as an Analgesic
March 09, 2011
Nutra Pharma Interviews Jeffrey Gottfurcht, World's First Climber with Rheumatoid Arthritis to Attempt to Scale Mount Everest
February 01, 2011
Nutra Pharma Announces Publication of a Review Article on Cobra Venom and its Use as an Analgesic
January 20, 2011
Nutra Pharma Announces Granted Continuing Education for Pharmacists
January 18, 2011
Nutra Pharma Sponsors Climber with Rheumatoid Arthritis to Scale World's Highest Mountain

2010

November 05, 2010
Nutra Pharma Awarded Grant under the Qualifying Therapeutic Discovery Project Program
October 26, 2010
Nutra Pharma Selects Nutritional Alliance as its Global Sales Agent
September 27, 2010
Nutra Pharma Introduces Nyloxin for Pets - a Treatment for Moderate to Severe Chronic Pain in Companion Animals
September 14, 2010
Nutra Pharma Amends Cobroxin Distribution Agreement with XenaCare Holdings
August 19, 2010
Nutra Pharma Begins Drug Registration Process in India for Nyloxin - a Treatment for Moderate to Severe Chronic Pain
August 09, 2010
Nutra Pharma Announces Amarey Nova Medical as its Exclusive Nyloxin Distributor in Colombia
August 06, 2010
Nutra Pharma Announces Second Quarter 2010 Sales and Distribution Update
July 28, 2010
Nutra Pharma Receives Patent for Novel Antiviral Treatment using Modified Cobra Venom
July 22, 2010
Nutra Pharma Drug Discovery Subsidiary to Introduce Novel Antiviral Therapy at the International AIDS Conference in Vienna, Austria
June 23, 2010
Nutra Pharma Begins Drug Registration Process in Central America for its Nyloxin Pain Reliever
June 10, 2010
Nutra Pharma Announces Grupo Farmaceutico de Tijuana as its Exclusive Nyloxin Distributor in Mexico
June 01, 2010
Nutra Pharma Partners with Henry Schein for Distribution of Nyloxin-Branded Pain Relievers
May 25, 2010
Nutra Pharma Announces First Manufacturing Release of Nyloxin Rx, a Prescription Treatment for Chronic Pain
May 12, 2010
Nutra Pharma Announces Publication of Research Report by Grass Roots Research and Distribution, Inc.
May 05, 2010
Nutra Pharma to Present and Exhibit at Las Vegas MoneyShow
April 26, 2010
UPDATE, TIME CHANGE: Nutra Pharma Hosts Press Conference at NASDAQ MarketSite, Tuesday, April 27th - 12:15pm EDT
April 20, 2010
Nutra Pharma Hosts Press Conference at NASDAQ MarketSite Tuesday, April 27th - 1:00pm EST
March 30, 2010
Over-the-Counter Pain Reliever, Cobroxin, Now Available in CVS
March 25, 2010
Nutra Pharma to Present and Exhibit at Upcoming Investment Conferences in Vancouver, Canada, and Las Vegas, Nevada
March 11, 2010
Nutra Pharma to Exhibit at the 12th IDGA Battlefield Healthcare Summit in Washington, D.C.
February 11, 2010
Nutra Pharma Hires David Isserman as Chief Marketing Officer
February 02, 2010
Nutra Pharma Announces Fourth Quarter Sales for its Over-the-Counter (OTC) Pain Reliever, Cobroxin
January 14, 2010
Nutra Pharma to Present and Exhibit at Upcoming Investment Conferences in Scottsdale, Arizona, and Orlando, Florida

2009

December 07, 2009
Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx - Over-the-Counter and Prescription Treatments for Chronic Pain
December 03, 2009
Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain
November 19, 2009
Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution
November 12, 2009
Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever
October 22, 2009
Nutra Pharma Announces Publication of Research Report by Cohen Independent Research Group
October 14, 2009
Nutra Pharma Announces Online Availability of Cobroxin for the Treatment of Moderate to Severe Chronic Pain
October 07, 2009
Nutra Pharma Announces Nyloxin Rx, a Prescription Analgesic for the Treatment of Severe (Stage 3) Chronic Pain
October 05, 2009
Online Financial Publication, CEO-CFO, Interviews Nutra Pharma Chairman and CEO
October 02, 2009
Nutra Pharma Announces Manufacturing Release of Cobroxin, a Treatment for Chronic Pain
September 24, 2009
The Wall Street Transcript Interviews Nutra Pharma Chairman and CEO
September 21, 2009
Nutra Pharma Announces Plans to Begin Drug Registration Process in Canada and Europe for its Over-the-Counter Pain Reliever
August 31, 2009
Nutra Pharma's Recently Launched Pain Reliever, Cobroxin, Wins "Best New Product" Award at Retailing Conference
August 26, 2009
Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market and Distribute Cobroxin, a Treatment for Chronic Pain
August 24, 2009
Nutra Pharma Completes FDA Submission for Cobroxin - a Drug for the Treatment of Stage 2 (Moderate to Severe) Chronic Pain
August 20, 2009
Nutra Pharma Announces Launch of Cobroxin, an Over-The-Counter (OTC) Treatment for Stage 2 (Moderate to Severe) Chronic Pain
August 13, 2009
Nutra Pharma Subsidiary, ReceptoPharm, Files Patent Application for the Oral Delivery of Cobra Venom for the Treatment of Pain
June 08, 2009
Nutra Pharma Announces Study Showing RPI-78 More Effective than Morphine in the Treatment of Moderate to Severe Pain
March 26, 2009
Nutra Pharma Subsidiary, ReceptoPharm, Introduces Cost Effective Contract Research Services for Early Stage Life Science Firms
March 09, 2009
Nutra Pharma Subsidiary, ReceptoPharm, Announces Achievement of ISO Class 5 Cleanroom Certification
February 17, 2009
Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Arthritis Study
February 09, 2009
Nutra Pharma Subsidiary, ReceptoPharm, Files Patent Application for Novel Treatment of Arthritis Using RPI-78

2007

December 27, 2007
Nutra Pharma Expands Licensing Agreement to Include Environmental Testing for NonTuberculous Mycobacterium
December 17, 2007
Nutra Pharma Announces Successful Completion of 6-Month Patient Crossover in AMN Clinical Trial
November 28, 2007
Nutra Pharma Posts ReceptoPharm Peer-Reviewed Article to Its Website
November 19, 2007
Nutra Pharma Announces Publication of Test Kit Technology in the International Journal of TB and Lung Diseases
November 08, 2007
Nutra Pharma Announces Designer Diagnostics Test Kit Technology to Be Presented at International Lung Health Conference
August 13, 2007
Shareholder Letter from Chairman and CEO Rik J. Deitsch
August 08, 2007
Nutra Pharma Announces Positive Results of ReceptoPharm Pain Study
July 10, 2007
Nutra Pharma Announces Successful Enrollment in ReceptoPharm Adrenomyeloneuropathy (AMN) Study
May 31, 2007
Nutra Pharma Announces Breakthrough with Rapid Tuberculosis Test Kit Technology
May 02, 2007
Nutra Pharma Announces Designer Diagnostics' Clinical Trials to Be Conducted at National Jewish Medical and Research Center
April 17, 2007
Nutra Pharma Announces Successful Completion of Joint Venture Meetings in China
April 11, 2007
Nutra Pharma Announces ReceptoPharm Patent for a Method of Treating Multiple Sclerosis
March 27, 2007
Nutra Pharma Completes First Royalty Payment to NanoLogix for Test Kit Technology
March 26, 2007
Nutra Pharma Sponsors Educational Website about Tuberculosis (TB) in Conjunction with World TB Day
March 22, 2007
Nutra Pharma Announces Publication of Research on Treatment for Multiple Sclerosis
March 07, 2007
Nutra Pharma Announces ReceptoPharm's Joint Venture with Chinese Biotechnology Company
March 01, 2007
Designer Diagnostics Engages U.S. Commercial Service for International Growth
February 28, 2007
Nutra Pharma Announces Partnership with World Aids Campaign
February 22, 2007
The Wall Street Transcript Interviews Nutra Pharma Chairman and CEO
February 14, 2007
Nutra Pharma Announces Shareholder Conference Call Scheduled for Wednesday, February 14, 2007
February 12, 2007
Nutra Pharma Chairman and CEO Outlines Business Strategy and Goals on CEOCast.com Interview
February 09, 2007
Nutra Pharma Announces Shareholder Conference Call to Discuss Recent News and Progress
February 08, 2007
National Television Series, Business & Beyond, to Feature Nutra Pharma on CNBC
February 07, 2007
ReceptoPharm Expands Antiviral Clinical Research to South America
January 29, 2007
ReceptoPharm Begins Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy
January 22, 2007
Shareholder Letter from Chairman and CEO Rik J. Deitsch
January 18, 2007
Designer Diagnostics Announces Positive Results from In-Vitro Analysis
January 16, 2007
Nutra Pharma Sponsors Educational Website for Adrenomyeloneuropathy (AMN)
January 11, 2007
Nutra Pharma Announces Breakthrough Research in the Treatment of Viral Infections
January 05, 2007
Nationally Distributed Magazine Publishes Article by Nutra Pharma Chairman and CEO Rik J Deitsch

2006

November 28, 2006
Nutra Pharma Announces ReceptoPharm to Present at the International Conference on Neurotoxins
November 21, 2006
Shareholder Letter from Chairman and CEO Rik J. Deitsch
November 03, 2006
Nutra Pharma Featured on Fox 2 News in St. Louis
October 31, 2006
Nutra Pharma Adopts Famous 2-Headed Snake of St. Louis World Aquarium
October 05, 2006
Nutra Pharma Announces Final Approval to Begin Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy
September 21, 2006
Nutra Pharma Announces ReceptoPharm to Be a Featured Speaker at the 11th Annual Immunobiology Symposium
August 31, 2006
Shareholder Letter from Chairman and CEO Rik J. Deitsch
August 29, 2006
Nutra Pharma Announces Former GlaxoSmithKline Global Clinical Development Director Joins ReceptoPharm Scientific Advisory Board
August 21, 2006
Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Pain Study
July 14, 2006
Business 2.0 Publishes Article about Nutra Pharma Corporation
July 13, 2006
WallSt.Net Publishes Interview with Nutra Pharma CEO Rik J. Deitsch
June 19, 2006
ReceptoPharm Signs Letter of Intent to Be Acquired by Nutra Pharma Corporation
May 31, 2006
Shareholder Letter from Chairman and CEO Rik J. Deitsch
May 09, 2006
Nutra Pharma Announces Approval to Start Late Phase II Human Trials in England
May 04, 2006
Nutra Pharma Sponsors Educational Website for Nontuberculous Mycobacterium (NTM)
May 03, 2006
The JALMA Institute Signs Purchase Agreement for Nutra Pharma's NTM Test Kits
April 19, 2006
Health on the Net Foundation Accredits Nutra Pharma Website
April 11, 2006
Nutra Pharma CEO Outlines Corporate Strategy on MacReport.Net
April 05, 2006
Nutra Pharma Launches Diagnostic Test Kits for the Rapid Identification of Nontuberculous Mycobacterium
March 31, 2006
Nutra Pharma Announces Svizera Labs to Supply Designer Diagnostics' Test Kits to the World Health Organization
March 21, 2006
Nutra Pharma Engages HealthForce LLC for Sales, Marketing and Distribution of Designer Diagnostics' Test Kits
March 16, 2006
Nutra Pharma Announces Full-Day Workshop in India to Introduce Designer Diagnostics' Test Kits
February 28, 2006
The Wall Street Transcript Publishes Interview With Nutra Pharma CEO Rik J. Deitsch
February 22, 2006
Nutra Pharma Accepted Into the Stop TB Partnership
February 09, 2006
Nutra Pharma Reports Preclinical Results of RPI-78M in Multiple Sclerosis to Be Presented at Scientific Meeting
February 06, 2006
Nutra Pharma Names Microbiologist and Former Infectech Executive to Head the Advisory Board of Designer Diagnostics
January 26, 2006
Nutra Pharma Incorporates Designer Diagnostics, Inc. -- a New Subsidiary to Market Medical Test Kits
January 25, 2006
Nutra Pharma Acquires Patents and Licenses for Medical Test Kits

2004

December 08, 2004
Nutra Pharma Engages Research Group to Validate Portage BioMed Technology
December 07, 2004
Nutra Pharma Corrects November 9, 2004 Press Release Stating "Nutra Pharma Signs Agreement to Acquire Portage BioMed"
November 19, 2004
Nutra Pharma Reports Infectech Engages Lake Erie Research Institute for FDA Submissions
November 15, 2004
Nutra Pharma Reports Preliminary Results of ReceptoPharm's Multiple Sclerosis Drug in Microarray Studies
November 15, 2004
Nutra Pharma Names Dr. Stewart Lonky to Board of Directors
November 09, 2004
Nutra Pharma Signs Agreement to Acquire Portage Biomed
November 03, 2004
Nutra Pharma Reports Further Validation of Infectech's Identikit Technology
October 05, 2004
Nutra Pharma Announces Board Changes and Loan Settlement
October 04, 2004
Nutra Pharma Reports Positive Results For ReceptoPharm's RPI-78M in Multiple Sclerosis Animal Model
September 29, 2004
Nutra Pharma Engages Equitilink LLC for Investor Relations
September 07, 2004
Nutra Pharma Reports Third Party Validation of Infectech's Identikit Technology
September 01, 2004
Nutra Pharma Reports ReceptoPharm Assays Prove That Experimental HIV Drug May Be Widely Available after Approval
August 30, 2004
Ohio State University Researcher Receives Competitive Grant Utilizing Infectech, Inc. Technology
August 02, 2004
Nutra Pharma Engages Research Group to Study RPI-78M in Multiple Sclerosis Assays
May 18, 2004
Nutra Pharma Reports ReceptoPharm's Completion of a Critical First Step in Their Lead Drug's Production
May 05, 2004
Nutra Pharma Reports Successful Completion of ReceptoPharm's HIV In-Vitro Studies at Two Leading Universities
April 28, 2004
Nutra Pharma Retains Rubenstein Investor Relations, Inc. as Investor Relations Consultants

 

 
Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.
 

 

 
Recent News
 
January 07, 2014
Nutra Pharma Announces the First Shipments and Product Delivery to MyNyloxin.com Independent Entrepreneurs


December 02, 2013
Nutra Pharma Finalizes Exclusive Network Marketing Distribution Agreement for Nyloxin


November 11, 2013
Nutra Pharma Provides Updates for the Marketing of Its All-Natural Pain Reliever, Nyloxin®


 
 
Announcements
Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
 
 
Facebook   Twitter
 
NPC
Privacy Policy Code of Ethics